Implantable Microdevice for TNBC - Pilot Study

NCT05774886 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped On hold

Conditions

Triple Negative Breast Cancer
Breast Cancer Stage II
Breast Cancer Stage III
Breast Cancer
Early Stage Triple-Negative Breast Carcinoma
Breast Neoplasms
Breast Carcinoma

Interventions

COMBINATION_PRODUCT: Implantable Microdevice (IMD)

Sponsor

Dana-Farber Cancer Institute